toxylact: a06ad17 sodium phosphate

The first professional lActological database in the word

Sodium phosphate (ATC A06AD17) is an osmotic laxative used orally and rectally for short‑term bowel cleansing and treatment of constipation; available data suggest low risk during breastfeeding when used as single or short courses, with attention to maternal fluid and electrolyte balance.medpedia.framar+4

Pharmacological class and clinical use

Sodium phosphate in class A06AD17 belongs to the group of osmotic laxatives acting primarily in the intestinal lumen. It is indicated for bowel cleansing prior to diagnostic or surgical procedures and for short‑term treatment of constipation when rapid evacuation is required. Oral solutions and rectal enemas increase intraluminal osmotic pressure, promoting water retention, stool softening and acceleration of colonic transit. Therapeutic use should be intermittent, and repeated or chronic administration is discouraged due to cumulative risks.atcddd.fhi+6

Mechanism of action and pharmacodynamics

Sodium phosphate acts as a saline osmotic agent that draws water into the intestinal lumen, increasing stool volume and stimulating mechanoreceptors in the colonic wall. Rectal preparations cause rapid distension of the rectum and distal colon, typically inducing defecation within 1–5 minutes after administration. The laxative effect is mainly local; however, systemic absorption of phosphate and sodium can occur, especially in susceptible patients or with excessive dosing. This systemic exposure underlies reported disturbances in fluid and electrolyte balance, renal function and, in extreme cases, cardiovascular complications.webmd+5

Toxicological profile

Local toxicity includes rectal irritation, pain, bleeding, mucosal necrosis and rarely perforation, particularly with forceful administration or pre‑existing anorectal disease. Systemic adverse effects arise from shifts in water and electrolytes, manifesting as severe dehydration, hypotension, hypernatremia, hyperphosphatemia, hypocalcemia and associated neuromuscular symptoms. High doses, repeated enemas or oral regimens close in time have been linked to acute kidney injury and cardiotoxicity, including arrhythmias, especially in patients with renal or cardiac impairment. Prolonged or inappropriate use may result in chronic electrolyte imbalance, bone pain and osteomalacia due to phosphate and calcium disturbances. Contraindications include megacolon, intestinal or rectal obstruction, severe inflammatory or ulcerative disease of the lower gastrointestinal tract and use in young children below age thresholds specified by individual products.allmed+5

Drug interactions and special populations

Concomitant use with diuretics and other agents affecting fluid and electrolyte balance can potentiate hypernatremia, hyperphosphatemia and hypocalcemia and requires caution. Additional caution is advised in patients receiving nephrotoxic drugs or medications that prolong the QT interval, due to the risk of electrolyte‑mediated cardiac events. In pregnancy, sodium phosphate laxatives are generally considered usable for short‑term indications, but risk–benefit assessment should focus on maternal hydration and comorbidities. Use is contraindicated or restricted in severe renal impairment, congestive heart failure and conditions predisposing to electrolyte imbalance, where alternative laxatives are preferred.medicines+5

Lactation safety and recommendations

Available lactation data and expert reviews indicate that phosphate‑based laxatives produce minimal transfer into breast milk and are considered compatible with breastfeeding in healthy term infants when used in standard doses. Studies and clinical experience suggest that single or short courses of oral sodium phosphate for bowel evacuation, and single rectal phosphate enemas, do not usually require interruption of breastfeeding. Some product information advises expressing and discarding breast milk from the first dose up to 24 hours after repeated oral dosing, reflecting a precautionary approach rather than documented infant harm. In lactating patients, preference should be given to intermittent use at the lowest effective dose, avoidance of repeated dosing, close monitoring for maternal dehydration and electrolyte disturbances, and consideration of alternative laxatives in women with renal, cardiac or significant metabolic disease.ncbi.nlm.nih+7

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.